When a person receives radiation for a tumor in the head or neck, the rays pass through healthy tissue as well. Sometimes the jawbone starts to die afterward — a severe complication called osteoradionecrosis. The question isn't whether it happens, but how much the radiation dose itself increases the risk.
The authors took data from 931 patients treated with a modern technique — volumetric modulated arc therapy. This method allows precise targeting of the radiation beam, but even so, part of the dose reaches the jaw. The scientists used causal machine learning to separate the effect of dose from other factors: age, disease stage, and overall health. It turned out that all studied dose parameters indeed cause an increased risk of bone death. On average, the effect ranged from 0.092 to 0.141—meaning that for each unit increase in dose, the risk of complication rises by about 9–14%.
This finding changes how treatment is planned. If a doctor knows the patient is 55, they can more strictly limit the dose to the jaw, while for a 75-year-old, they might not be as strict. This approach is called personalized medicine: treatment is tailored to the individual, not to average numbers. The method used in this study can also be applied to other complications of radiation therapy — for example, damage to the salivary glands or the lining of the mouth.
Rays that kill a tumor can also wound healthy bone. But now doctors can see who is most at risk and can deflect the blow in advance.
Osteoradionecrosis of the jaw can develop even several years after radiation therapy ends, the bone seems to 'remember' the dose it received.